FindTrial
Sign In

Our experience in the usage of thoracic epidural analgesia in patients donating the liver for transplant purpose

Thoracic epidural analgesia in donor hepatectomy : our experience

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2016/09/007247
Enrollment
120
Registered
2016-09-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patient undergoing donor hepatectomy

Interventions

None listed

Sponsors

Sir Ganga Ram Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients undergoing donor hepatectomy

Exclusion criteria

Exclusion criteria: age less than 18 years

Design outcomes

Primary

MeasureTime frame
To evaluate the safety of thoracic epidural analgesia in terms of 1. quality of post operative analgesia 2. changes in coagulation profile in post operative period and timing of removal of epidural catheter 3. Incidence of epidural catheter related complicationsTimepoint: 1. Entire intraoperative period 2. Post operatively everyday until epidural catheter removal—

Secondary

MeasureTime frame
1. Effect of thoracic epidural analgesia on intraoperative haemodynamic parameters, central venous pressure 2.assessing whether duration of surgery, volume infused, residual liver volume and hypocalcemia increase the risk of coagulopathy in these patientsTimepoint: day 1, 2, 3, 4, 5—

Countries

India

Contacts

Public ContactDr Archna Koul

Sir Ganga Ram Hospital

archnakoul1@gmail.com09958892622

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026